Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
Active, not recruiting · NCT05200988 · Registry updated 2024-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urothelial carcinoma | Active, not recruiting | Phase 2 | 2024-03-18 | NCT05200988 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| The Netherlands Cancer Institute | 113 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Antoni van Leeuwenhoek ziekenhuis | Amsterdam | Netherlands | 1 |
| Erasmus Medical Center | Rotterdam | Netherlands | 36 |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | 13 |